Trial intelligence / Profile preview

Acthar Gel in diabetic nephropathy with nephrotic range proteinuria

NCT01028287Phase 4Completed

Sponsor
Southeast Renal Research Institute
Start
May 2009
Primary completion
Dec 2010
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

A Phase 4 trial of repository corticotropin injection in diabetic nephropathy (DN), nephrotic syndrome, sponsored by Southeast Renal Research Institute. Started May 2009; status: completed.

02

Drugs

repository corticotropin injection
03

Conditions

diabetic nephropathy (DN)nephrotic syndrome

Beyond the preview

Go deeper on NCT01028287.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01028287.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call